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Novel ALDH3A2 Heterozygous Mutations Are Associated with
Defective Lamellar Granule Formation in a Japanese Family of
Sjo¨gren–Larsson Syndrome
To the Editor:
Sjo¨gren–Larsson syndrome (SLS: MIM# 270200) is an au-
tosomal recessive disorder characterized by congenital
ichthyosis, mental retardation, and spastic paresis (Rizzo,
1993). Rizzo et al (1988) demonstrated that long-chain fatty
alcohol was deposited in cultured fibroblasts, white blood
cells, and serum in SLS patients. Later, De Laurenzi et al
(1996) reported that mutations in the fatty aldehyde de-
hydrogenase (FALDH) gene (ALDH3A2) were responsible for
the development of SLS. However, the exact pathomech-
anisms of this ichthyosis in SLS is not fully understood.
In this study, we report novel heterozygous mutations in
ALDH3A2 in a Japanese family with SLS. In this family, a
combination of heterozygous mutations is associated with
defective lamellar granules and abnormal intercellular lipid
in the stratum corneum.
Case 1: A 6-year-old girl with congenital ichthyosis,
mental retardation, and spastic paresis in both her lower
extremities, visited our clinic (Fig 1A). Physical examination
revealed xerosis and fine scales over her whole body, and
lamellar-shaped scales on her dorsal hands and feet. Her
lower extremities were hypertonic. Brain magnetic reso-
nance imaging (MRI) demonstrated a high-intensity area in
the postangular area of the left parietal lobe. Ophthalmo-
logic examination was unremarkable.
Case 2: A 1-year-old boy, the younger brother of case 1,
was brought to our clinic suffering from congenital
ichthyosis, mental retardation, and spastic paresis on both
his lower extremities. Physical examination revealed brown-
colored pigmentation with mild to moderate hyperkerato-
sis on his neck, with fine, dark scales on the dorsal feet
(Fig 1B). No other abnormalities, including ophthalmologic
problems, were observed.
To elucidate the genetic abnormality of the patients,
blood samples were collected from both patients and their
parents. All the experiments, skin biopsies and blood
sampling were performed with the parents’ written informed
consent and with the institutional approval of Hokkaido
University Graduate School of Medicine for experiments
handling human matter in accordance with Helsinki Princi-
ples. The ALDH3A2 gene was amplified by the methods
previously reported by Rizzo et al (1999). DNA sequencing
of all the PCR products was carried out using a Genetic
Analyzer 310A automatic sequencer (Perkin-Elmer Life
Sciences-ABI, Foster City, California). In both children, we
detected a combination of heterozygous mutations in exon
4 and 7 (Fig 1C). The mutation in exon 4 (481delA) was
only present in their mother, and the mutation in exon 7
Figure1
Clinical features and fatty aldehyde dehydrogenase (FALDH) gene
(ALDH3A2) mutations. (A) Low magnification clinical view of case 1.
Xerotic skin and fine scales over the entire body and spastic paresis on
both lower extremities. (B) High magnification clinical view of case 2.
Fine gray scales present on the dorsal feet. (C) Sequence analysis of
the ALDH3A2. A combination of heterozygous mutations derived from
their mother (481delA in exon 4) and father (1087–1089delGTA in exon
7) were detected. (D) A sequence alignment between the FALDH, rat
class 3 and human class 1 and class 2 ALDH showing the relative
locations of key residues in these enzymes. Strictly conserved residues
are highlighted in red, while highly conserved residues are shown in
blue. Secondary structure components found in the class 3 rat ALDH
structure are presented in blue, bars represent a-helices and arrows
represent b-strands. (Modified from the paper by Liu et al, 1997.)
Abbreviations: ALDH, aldehyde dehydrogenase; FALDH, fatty
aldehyde dehydrogenase; SLS, Sjo¨gren–Larsson syndrome
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(1087–1089delGTA) was only demonstrated in their father.
The presence of both these mutations was excluded in 100
alleles of 50 normal unrelated Japanese individuals.
Histopathological examination of the skin biopsy spec-
imens obtained from both cases revealed orthohyper-
keratosis with mild hypergranulosis (Fig 2A). Electron
microscopic examination of osmium tetroxide-fixed sam-
ples from the lesional skin of both patients, demonstrated
the abnormal lamellar granules lacking the normal lamellar
contents (Fig 2B). Some of the defective lamellar granules
secreted their components into the intercellular space
in the stratum corneum. Irregularly shaped granular and
electron-lucent materials were also deposited in the dilated
intercellular space between corneocytes (Fig 2C–E ).
Variously sized empty vacuoles, presumably containing
electron lucent lipid, were also seen in the stratum corneum
(Fig 2B, C).
Immunofluorescent staining for keratin 1, 10, loricrin, and
involucrin, performed as described previously (Akiyama
et al, 1998), revealed that all of these molecules were nor-
mally distributed in the epidermis (data not shown). The
distribution pattern of a trans-Golgi network marker, TGN-46
and a lamellar granule component, cathepsin D (Ishida-
Yamamoto et al, 2004) were normal, although immunofluo-
rescent staining for glucosylceramides revealed an abnormal,
irregular or granular distribution of glucosylceramides in the
patients’ stratum corneum (data not shown).
Normal epidermal transglutaminase activity was con-
firmed in both patients by the in situ transglutaminase
activity assays previously described elsewhere (Hohl et al,
1998; Raghunath et al, 1998; Akiyama et al, 2001) (data not
shown).
FALDH is a microsomal NAD-dependent enzyme,
which is necessary for the oxidation of long-chain
aliphatic aldehydes to fatty acids (Kelson et al, 1997).
Until now, several mutations in ALDH3A2 have been shown
to be responsible for SLS around the world (Rizzo et al,
1999).
In our cases, a heterozygous combination of two novel
mutations has been identified. The maternal mutation 481-
delA in exon 4 resulted in a frame-shift leading to a stop
codon at codon 522. This premature translation termination
eliminates the downstream 64% of ALDH3A2 coding se-
quences. The paternal mutation 1087–1089delGTA in exon
7 resulted in a deletion of valine at position 363 of FALDH
protein. According to a comparison of 145 full-length
ALDH-related sequences by Perozich et al (1999), this
valine is highly conserved among many of the ALDH
family members, and participates in one of the ten most
conserved sequence motifs in ALDH. In addition, analysis of
the crystallized 3-D structure of the related class 3 rat
cytosolic ALDH revealed that this valine is located at one of
the six parallels of b-strands, b11, comprising the catalytic
domain of the molecule (Fig 1D) (Liu et al, 1997). These
findings strongly suggest that valine at position 363 is im-
portant for structural folding of the catalytic domain and are
therefore essential for the normal function of the FALDH
protein.
Previously, abnormal lamellar or membranous inclu-
sions in the cornified cells were observed in the lesional
skin of a SLS patient, although causative genetic abnor-
malities were not known in that particular case (Ito
et al, 1991). The inclusions were speculated to be lamellar
granule-in-origin. Later, a deficiency in acyl-ceramides in
the lipid layer in the stratum corneum was also reported
in SLS patients (Paige et al, 1994). In addition to these
previous observations, we revealed that the malformed
lamellar granule components were secreted into the
intercellular space, and irregular-shaped granular and elec-
tron-lucent materials were deposited in the irregularly
dilated intercellular space in stratum corneum. Immunoflu-
orescence studies revealed an abnormal distribution
of glycosylceramide, a lamellar granule component, in the
patients’ stratum corneum. These observations together
suggest defective lamellar granule formation in these
patients.
Similarly, a large number of abnormal lamellar granules
associated with disturbed intercellular lamellar structures
were observed in ichthyotic skin in a patient with Dorfman–
Chanarin syndrome (Akiyama et al, 2003). Furthermore,
in harlequin ichthyosis, lamellar granules are completely
absent or, if present, are not correctly secreted into the
intercellular space (Milner et al, 1992). Thus, the present
ultrastructural and immunofluorescence findings suggest
that formation of defective lamellar granule contents and
defective intercellular lipids, presumably related to the mu-
tations in ALDH3A2, may lead to the ichthyotic skin devel-
oped in SLS patients.
Figure 2
Morphological features of the patient’s epidermis. (A) Histopathol-
ogy of ichthyotic skin lesion of case 1. Orthohyperkeratosis with mild
hypergranulosis was observed. (B) Ultrastructurally, at the stratum
granulosum/stratum corneum interface, abnormal apparently empty
lamellar granules (white arrowheads) were seen in the granular cells and
lipid vacuoles (white arrows) were observed in the cornified cells. (C–E )
Vacuoles, presumably lipid droplets (white arrows) and irregularly
shaped abnormal intercellular materials (black arrows) were apparent in
the stratum corneum layers. Scale bars¼ 50 (A) and 0.3 mm (B–E).
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